Drug Study for Cervical and Vaginal Cancers

Testing the Addition of a New Anti-Cancer Drug for Advanced-Stage Cervical and Vaginal Cancers

cervical cancer


AGE: >18 years old
GENDER: Female
TYPE: Drug study
CONDITION: Advanced-stage cervical and vaginal cancers

Learn More About This Research Study

For more information, please contact Lauren Patrick at 216-844-8724 or complete the online form below.

Study Purpose

A Randomized Phase III Trial of Radiation Therapy and Cisplatin Alone or in Combination with Intravenous Triapine in Women with Newly Diagnosed Bulky Stage IB2, Stage II, IIIB, or IVA Cancer of the Uterine Cervix or Stage II-IVA Vaginal Cancer

The purpose of this study is to confirm the effectiveness of the combination of triapine with usual cisplatin and radiation therapy in patients with advanced-stage cervical or vaginal cancer.

Who Can Participate

Participants 18 years and older diagnosed with advanced stage adenocarcinoma or adenosquamous carcinoma of the uterine cervix or the vagina not amenable to curative surgical resection alone may be eligible for this study.

Request More Information

To learn more about this study, please fill out the form below to request more information.


Study ID